IE37134B1 - Antibacterial compositions - Google Patents
Antibacterial compositionsInfo
- Publication number
- IE37134B1 IE37134B1 IE100/73A IE10073A IE37134B1 IE 37134 B1 IE37134 B1 IE 37134B1 IE 100/73 A IE100/73 A IE 100/73A IE 10073 A IE10073 A IE 10073A IE 37134 B1 IE37134 B1 IE 37134B1
- Authority
- IE
- Ireland
- Prior art keywords
- alanine
- fluoro
- antibacterial compositions
- methylisoxazolidin
- cycloserine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 3
- UYTSRQMXRROFPU-UWTATZPHSA-N (2s)-2-amino-3-fluoropropanoic acid Chemical compound FC[C@@H](N)C(O)=O UYTSRQMXRROFPU-UWTATZPHSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 abstract 2
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- UYTSRQMXRROFPU-MIRRBZTDSA-N (2s)-2-amino-2,3,3-trideuterio-3-fluoropropanoic acid Chemical compound [2H]C([2H])(F)[C@@]([2H])(N)C(O)=O UYTSRQMXRROFPU-MIRRBZTDSA-N 0.000 abstract 1
- UYTSRQMXRROFPU-BMRKBTMXSA-N (2s)-2-amino-2,3-dideuterio-3-fluoropropanoic acid Chemical compound [2H]C(F)[C@@]([2H])(N)C(O)=O UYTSRQMXRROFPU-BMRKBTMXSA-N 0.000 abstract 1
- UYTSRQMXRROFPU-LIIDHCAMSA-N (2s)-2-amino-2-deuterio-3-fluoropropanoic acid Chemical compound FC[C@](N)([2H])C(O)=O UYTSRQMXRROFPU-LIIDHCAMSA-N 0.000 abstract 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 abstract 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 abstract 1
- ODKYYBOHSVLGNU-UHFFFAOYSA-N 4-[[4-[(3-oxo-1,2-oxazolidin-4-yl)iminomethyl]phenyl]methylideneamino]-1,2-oxazolidin-3-one Chemical compound O=C1NOCC1N=CC(C=C1)=CC=C1C=NC1C(=O)NOC1 ODKYYBOHSVLGNU-UHFFFAOYSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 102000003960 Ligases Human genes 0.000 abstract 1
- 108090000364 Ligases Proteins 0.000 abstract 1
- DEFJQIDDEAULHB-UHFFFAOYSA-N N-D-alanyl-D-alanine Natural products CC(N)C(=O)NC(C)C(O)=O DEFJQIDDEAULHB-UHFFFAOYSA-N 0.000 abstract 1
- 102000003929 Transaminases Human genes 0.000 abstract 1
- 108090000340 Transaminases Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 108010056243 alanylalanine Proteins 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22336072A | 1972-02-03 | 1972-02-03 | |
| US31487872A | 1972-12-13 | 1972-12-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE37134L IE37134L (en) | 1973-08-03 |
| IE37134B1 true IE37134B1 (en) | 1977-05-11 |
Family
ID=26917692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE100/73A IE37134B1 (en) | 1972-02-03 | 1973-01-23 | Antibacterial compositions |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE794913A (OSRAM) |
| CA (1) | CA1024448A (OSRAM) |
| DE (1) | DE2262787C2 (OSRAM) |
| FR (1) | FR2181703B1 (OSRAM) |
| GB (1) | GB1421023A (OSRAM) |
| HK (1) | HK86479A (OSRAM) |
| IE (1) | IE37134B1 (OSRAM) |
| IL (1) | IL41358A (OSRAM) |
| NL (1) | NL177183C (OSRAM) |
-
1972
- 1972-12-21 DE DE2262787A patent/DE2262787C2/de not_active Expired
-
1973
- 1973-01-16 NL NLAANVRAGE7300636,A patent/NL177183C/xx not_active IP Right Cessation
- 1973-01-22 IL IL41358A patent/IL41358A/en unknown
- 1973-01-23 IE IE100/73A patent/IE37134B1/xx unknown
- 1973-01-24 CA CA161,913A patent/CA1024448A/en not_active Expired
- 1973-01-29 GB GB442673A patent/GB1421023A/en not_active Expired
- 1973-02-02 BE BE794913D patent/BE794913A/xx not_active IP Right Cessation
- 1973-02-02 FR FR7303668A patent/FR2181703B1/fr not_active Expired
-
1979
- 1979-12-20 HK HK864/79A patent/HK86479A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE794913A (fr) | 1973-08-02 |
| GB1421023A (en) | 1976-01-14 |
| FR2181703A1 (OSRAM) | 1973-12-07 |
| DE2262787A1 (de) | 1973-08-09 |
| NL177183B (nl) | 1985-03-18 |
| IL41358A (en) | 1976-03-31 |
| IL41358A0 (en) | 1973-03-30 |
| CA1024448A (en) | 1978-01-17 |
| FR2181703B1 (OSRAM) | 1975-11-21 |
| NL7300636A (OSRAM) | 1973-08-07 |
| DE2262787C2 (de) | 1982-09-23 |
| IE37134L (en) | 1973-08-03 |
| HK86479A (en) | 1979-12-28 |
| NL177183C (nl) | 1985-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1320076A (en) | Therapeutic compositions containing 3-4-biphenylcarbonyl propionic acid | |
| GB1388358A (en) | Taste-improving formulations of oral penicillins | |
| GB1431323A (en) | Aminonaphthalenesulphonic acids | |
| GB1455049A (en) | Process for the manufacture of 3- 3,4-dihydroxy-phenyl-serine | |
| ES8400488A1 (es) | Un procedimiento para la preparacion de la sustancia f.r.-48756 acido 1-(6-amino-9-h-purin-9-il)-1,3-didedoxo-3-(o-metil l-tirosilamino)-b-d-ribofuranuronico. | |
| GB1397645A (en) | Aza-benzimidazoles | |
| GB1388790A (en) | Alpha- 3-trifluormethylphenoxy-4-chlorobenzyl-heterocycles their preparation and compositions containing them | |
| IE37134B1 (en) | Antibacterial compositions | |
| ES8800235A1 (es) | Un procedimiento para preparar un isomero sin de un compues-to de cefem | |
| GB1325529A (en) | Aminophenylamidines their production and their medicinal use | |
| GB1322482A (en) | Glutamic acid derivatives their preparation and compositions containing the same | |
| GB1379526A (en) | Benzothiazol-phenyl-acetic acid compounds | |
| GB1288647A (OSRAM) | ||
| GB1433270A (en) | Benzopyrano-2,3-c-pyrazolecarboxylic acids their preparation and compositions containing them | |
| GB1314231A (en) | Pepsin inhibitors | |
| AU2001274005A1 (en) | Pourable feed additives containing d-pantothenic acid and/or salts thereof, and process for their preparation | |
| GB1261660A (en) | alpha-HYDRAZINO ACIDS | |
| NZ505080A (en) | Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid | |
| GB1486395A (en) | Cardiac stimulant | |
| IE39587L (en) | Antibacterial composition | |
| GB1427882A (en) | Oxytetracycline solutions | |
| GB1303935A (OSRAM) | ||
| ES8602812A1 (es) | Un procedimiento para obtener esteres de cefalosporina | |
| GB1343409A (en) | Preparation of l-a-hydrazino-beta-phenylpropionic acid compounds | |
| IE33581B1 (en) | Method of treatment and pharmaceutical preparation |